Investigation of Fetuin-A pathway in diabetes mellitus formation in rats exposed to elf magnetic fields

References

• Ahlbom, A., N. Day, M. Feychting, E. Roman, J. Skinner, J. Dockerty, M. Linet, M. McBride, J. Michaelis, J. H Olsen, et al. 2000. A pooled analysis of magnetic fields and childhood leukaemia. British Journal of Cancer 83:692–98. doi:10.1054/bjoc.2000.1376.
   PubMed Web of Science ®Google Scholar
• Andersen, G., K. S. Burgdorf, T. Sparso, K. Borch-Johnsen, T. Jørgensen, T. Hansen, and O. Pedersen. 2008. AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia. Diabetes 57:1427–32. doi:10.2337/db07-0558.
   PubMed Web of Science ®Google Scholar
• Bonhomme-Faifre, L., S. Marıson, F. Forestıer, R. Santını, and H. Auclaır. 2003. Effects of electromagnetic fields on the immune system of occupationally exposed humans and mice. Archives of Environmental Health: An International Journal 58:712. doi:10.3200/AEOH.58.11.712-717.
   PubMedGoogle Scholar
• Carpenter , Da‘d , Sage, C‘ndy (Eds.). August 31,2007. BioInitiative Report: A rationale for a biologically-based public exposure standard for electromagnetic fields (ELF and RF). www.bioinitiative.org
   Google Scholar
• Chater, S., H. Abdelmelek, M. Sakly, J. M. Pequinot, and R. K. Ben. 2006. Effects of sub-acute exposure to magnetic field on blood hematological and biochemical parameters in female rats. Turk J Hematol 23:182–87.
   PubMedGoogle Scholar
• Forgacs, Z., G. Thuroczy, K. Paksy, and L. D. Szabo. 1998. Effect of sinusoidal 50 Hz magnetic field on the testosterone production of mouse primary Leydig cell culture. Bioelectromagnetics 19:429–31. doi:10.1002/(SICI)1521-186X(1998)19:7<429::AID-BEM4>3.0.CO;2-3.
   PubMed Web of Science ®Google Scholar
• Havas, M. 2000. Biological effects of non-ionizing electromagnetic energy: A critical review of the reports by the US national research council and the US national institute of environmental health sciences as they relate to the broad realm of EMF bioeffects. Environmental Reviews 8:173–253. doi:10.1139/a00-004.
   Google Scholar
• Havas, M. 2006. Electromagnetic hypersensitivity: Biological effects of dirty electricity with emphasis on diabetes and multiple sclerosis. Electromagnetic Biology and Medicine 25:259–68. doi:10.1080/15368370601044192.
   PubMed Web of Science ®Google Scholar
• Havas, M. 2008. Dmitry electricity elevates blood sugar among electrically sensitive diabetics and may explain brittle diabetes. Electromagn Biol Med 27:2144–51. doi:10.1080/15368370802072075.
   Web of Science ®Google Scholar
• Heredia-Rojas, J. A., D. E. Caballero-Hernandez, F. Rodriguez, G. Ramos-Alfano, and L. E. Rodriguez- Flores. 2004. Lack of alterations on meiotic chromosomes and morphological characteristics of male germ cells in mice exposed to a 60 Hz and 2.0 mT magnetic field. Bioelectromagnetics 25:63–68. doi:10.1002/bem.10184.
   PubMed Web of Science ®Google Scholar
• Ismail, N. A., S. Ragab, S. M. Abd El Dayem, A. A. Elbaky, N. Salah, M. Hamed, H. Assal, and H. Koura. 2012. Fetuin-A levels in obesity: Differences in relation to metabolic syndrome and correlation with clinical and laboratory variables. Archives of Medical Science 5:826–3. doi:10.5114/aoms.2012.31616.
   Google Scholar
• Ix, J. H., G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley. 2006. Fetuin-A and kidney function in persons with coronary artery disease: Data from the heart and soul study. Nephrology Dialysis Transplantation 21:2144–51. doi:10.1093/ndt/gfl204.
   PubMed Web of Science ®Google Scholar
• Ix, J. H., G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley. 2007. Association of Fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: Data from the heart and soul study. Circulation 115:2533–39. doi:10.1161/CIRCULATIONAHA.106.682450.
   PubMed Web of Science ®Google Scholar
• Ix, J. H., Wassel, C.L., Kanaya, M.A., et al. 2008. Fetuin-A and in- cident diabetes mellitus in older persons. JAMA 300:182–88. doi:10.1001/jama.300.2.182.
   PubMed Web of Science ®Google Scholar
• Joshi, N. J., S. B. Moodbidri, and T. D. Nandedkar. 1987. Inhibition of A5-3p hydroxysteroid dehydrogenase activity in pre-implantation mouse embryos and their implantation by sheep ovarian follicular fluid peptide. Acta Endocrinol. 115:183–88. doi:10.1530/acta.0.1150183.
   PubMedGoogle Scholar
• Kundi, M., K. Hansson Mild, L. Hardell, M.O Mattsson, et al. 2004. Mobile telephones and cancer—a review of epidemiological evidence. Journal of Toxicology and Environmental Health, 7:351–84. doi:10.1080/10937400490486258.
   Google Scholar
• Lai, H., and N. P. Singh. 2005. Interaction of microwaves and a temporally incoherent magnetic field on single and double DNA strand breaks in rat brain cells. Electromagnet. Biol. Med. (Formerly Electro- and Magnetobiol) 24:23–29.
   Web of Science ®Google Scholar
• Lavebratt, C., E. Dungner, and J. Hoffstedt. 2005. Polymorphism of the AHSG gene is associated with increased adipocyte ß2-adrenoceptor function. Journal of Lipid Research 46:2278–81. doi:10.1194/jlr.M500201-JLR200.
   PubMed Web of Science ®Google Scholar
• Lee, J. S., S. S. Ahn, K. C. Jung, Y. W. Kirn, and S. K. Lee. 2004. Effects of 60 Hz electromagnetic field exposure on testicular germ cell apoptosis in mice. Asian. J. Androl 6:29–34.
   PubMed Web of Science ®Google Scholar
• Li, L., Y. Dai, R. Xia, S. Chen, D. Qiao. 2005. Pulsed electric field exposure of insulin induces anti-proliferative effects on human hepatocytes. Bioelectromagnetics 26:639–47. doi:10.1002/bem.20156.
   PubMed Web of Science ®Google Scholar
• Li, D.-K., R. Odouli, S. Wi, T. Janevic, I. Golditch, T. D. Bracken, R. Senior, R. Rankin, R. Iriye. 2002. A Population-Based Prospective Cohort Study of personal exposure to magnetic fields during pregnancy and the risk of miscarriage. Epidemiology 13:9–20. doi:10.1097/00001648-200201000-00004.
   PubMed Web of Science ®Google Scholar
• Mori, K., M. Emoto, T. Araki, H. Yokoyama, E. Lee, M. Teramura, H. Koyama, T. Shoji, M. Inaba, Y. Nishizawa, et al. 2008. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism 57:1248–52. doi:10.1016/j.metabol.2008.04.019.
   PubMedGoogle Scholar
• Mori, K., M. Emoto, T. Araki, H. Yokoyama, M. Teramura, E. Lee, K. Motoyama, H. Koyama, T. Shoji, M. Inaba, et al. 2007. Association of serum fetuin-A with carotid arterial stiffness. Clinical Endocrinology 66:246–50. doi:10.1111/j.1365-2265.2006.02716.x.
   PubMed Web of Science ®Google Scholar
• Mori, K., M. Emoto, H. Yokoyama, T. Araki, M. Teramura, H. Koyama, T. Shoji, M. Inaba, and Y. Nishizawa. 2006. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 29:468. doi:10.2337/diacare.29.02.06.dc05-1484.
   PubMed Web of Science ®Google Scholar
• Ou, H. Y., Y. C. Yang, H. T. Wu, J. S. Wu, F. H. Lu, and C. J. Chang. 2011. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tol- erance and newly diagnosed type 2 diabetes. Clinical Endocrinology 75:450–55. doi:10.1111/j.1365-2265.2011.04070.x.
   PubMed Web of Science ®Google Scholar
• Reinehr, T., and C. L. Roth. 2008. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. The Journal of Clinical Endocrinology & Metabolism 93:4479–85. doi:10.1210/jc.2008-1505.
   PubMed Web of Science ®Google Scholar
• Sakuraı, T., S. Koyama, Y. Komatsubara, W. Jın, and J. Mıyakoshı. 2005. Decrease in glucose-stimulated insülin secretion following exposure to magnetic fields. Biochemical and Biophysical Research Communications 332:28. doi:10.1016/j.bbrc.2005.04.091.
   PubMed Web of Science ®Google Scholar
• Sakurai, T., A. Satake, S. Sumi, K. Inoue, J. Miyakoshi. 2004. An extremely low frequency magnetic field attenuates insulin secretion from the insulinoma cell line. RIN-m. Bioelectromagnetics 25:160–66. doi:10.1002/bem.10181.
   PubMed Web of Science ®Google Scholar
• Sato, H., J. J. Kazama, Y. Wada, T. Kuroda, I. Narita, F. Gejyo, P. Gao, H. Yamashita. 2007. Decreased levels of circulating Į2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis. Internal Medicine 46:1685–92. doi:10.2169/internalmedicine.46.6269.
   PubMed Web of Science ®Google Scholar
• Shokrzadeh, M., and S. S. Saeedi Saravi. 2009. Influence of electromagentic field exposure on serum glucose and cortisol levels in Guinea pigs. Toxicol Environ Chem 91:717–21. doi:10.1080/02772240802407076.
   Google Scholar
• Siddiq, A., F. Lepretre, S. Hercberg, P. Froguel, and F. Gibson. 2005. A synonymous coding polymorphism in the α2-Heremans-Schmid glycoprotein gene is associated with type 2 diabetes in French caucasians. Diabetes 54:2477–81. doi:10.2337/diabetes.54.8.2477.
   PubMed Web of Science ®Google Scholar
• Sieron, A., H. Brus, J. Konecki, G. Cieslar, R. Szkilnik, P. Nowak, T. Noras, A. Kwiecinski, R. M. Kostrzewa, and R. Brus. 2007. Effect of low frequency electromagnetic fields on [3h]glucose uptake in rat tissues. Polish J. of Environ. Stud 16:309–312.
   Web of Science ®Google Scholar
• Stefan, N., A. M. Hennige, H. Staiger, J. Machann, F. Schick, S. M. Kröber, F. Machicao, A. Fritsche, H.-U. Häring. 2006. α2-Heremans-Schmid glycoprotein/Fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853–57. doi:10.2337/diacare.29.04.06.dc05-1938.
   PubMed Web of Science ®Google Scholar
• Stejskal, D., M. Karpisek, R. Vrtal, V. Student, P. Solichova, R. Fiala, and P. Stejskal. 2008. Urine fetuin-A values in relation to the presence of urolithiasis. BJU International 101:1151–54. doi:10.1111/j.1464-410X.2007.07432.x.
   PubMed Web of Science ®Google Scholar
• Tönjes, A., M. Fasshauer, J. Kratzsch, M. Stumvoll, M. Blüher, and K. Maedler. 2010. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One 5:e13911. doi:10.1371/journal.pone.0013911.
   PubMed Web of Science ®Google Scholar
• Tsuji, Y., M. Nakagawa, and Y. Suzuki. 1996. Five-tesla static magnetic fields suppress food and water consumption and weight gain in mice. Industrial HEALTH 34:347–57. doi:10.2486/indhealth.34.347.
   PubMed Web of Science ®Google Scholar
• U.S. Census Bureau. 2005. Total midyear population for the world: 1950-2050. www.census.gov/ipe/www/worldpop.htmal (April 26,2005)
   Google Scholar
• Vörös, K., L. GráfsJr, Z. Prohászka, L. Gráf, P. Szenthe, E. Kaszás, Z. Böröcz, K. Cseh, and L. Kalabay. 2011. Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction. European Journal of Clinical Investigation 41:703–09. doi:10.1111/j.1365-2362.2010.02456.x.
   PubMed Web of Science ®Google Scholar
• Wild, S., G. Roglic, A. Green, R. Sicree, H. King. 2004. Global prevalence of diyabetes. Diabetes Care 27:1047–53. doi:10.2337/diacare.27.5.1047.
   PubMed Web of Science ®Google Scholar
• Yerlikaya, F. H., and I. Mehmetoğlu. 2012. Fetuin- A and its physiopathologic effects: Review. Turkiye Klinikleri J Endocrin 7:21–27.
   Google Scholar
• Zare, S., H. Hayatgeibi, S. Alivandi, and A. G. Ebadi. 2005. Effects of whole-body magnetic field on changes of glucose and cortisol hormone in Guinea pigs. Am J Biochem Biotechnol 1:217–19. doi:10.3844/ajbbsp.2005.217.219.
   Google Scholar